Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms

被引：6

作者：

Yang, Zhihua ^{[1
,2
]}

Liu, Yangxi ^{[1
]}

Song, Zhihui ^{[2
]}

Fan, Yujian ^{[1
]}

Lin, Shanshan ^{[1
]}

Ge, Zhao ^{[1
]}

Feng, Shaoling ^{[1
]}

Liu, Yu ^{[1
]}

Bi, Yingfei ^{[1
]}

Wang, Yi ^{[1
]}

Wang, Xianliang ^{[1
]}

Mao, Jingyuan ^{[1
]}

机构：

[1] Tianjin Univ Tradit Chinese Med, Natl Clin Res Ctr Chinese Med Acupuncture & Moxibu, Teaching Hosp 1, Tianjin 300381, Peoples R China

[2] Tianjin Univ Tradit Chinese Med, Inst Tradit Chinese Med, Tianjin 301617, Peoples R China

来源：

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2023年 / 20卷 / 08期

基金：

中国国家自然科学基金;

关键词：

coronary microvascular disease; traditional Chinese medicine; Chinese patent medicines; clinical evidence; potential; Coronary microvascular disease (CMVD) refers; C-REACTIVE PROTEIN; REPERFUSION INJURY; NO-REFLOW; DYSFUNCTION; TONGXINLUO; PATHOPHYSIOLOGY; PHOSPHORYLATION; INFLAMMATION; RESISTANCE; ISCHEMIA;

D O I：

10.7150/ijms.85789

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Coronary microvascular disease (CMVD) is a high risk factor for many cardiovascular events. Due to the limited understanding of its pathophysiological mechanism, modern medicine still lacks therapeutic drugs for CMVD. Existing clinical studies have shown that traditional Chinese medicine (TCM) can effectively improve the clinical symptoms and quality of life of CMVD patients. As an indispensable part of TCM, Chinese patent medicines (CPMs) are widely used in clinical practice. In the face of numerous oral CPMs for treatment of CMVD, how to choose a reasonable medication regimen is one of the important issues in clinic. Based on this, this paper reviewed the clinical efficacy and recommended level of 12 CPMs in the treatment of CMVD, which are recommended by expert consensus on diagnosis and treatment of coronary microvascular disease with integrated Chinese and Western medicine (WM). In addition, this study also systematically summarized the possible mechanisms of CPMs in the treatment of CMVD by protecting coronary microvascular endothelial cells, improving vascular endothelial function, inhibiting inflammation, reducing oxidative stress, promoting angiogenesis, and improving hemorheology, aiming to provide meaningful information for its clinical application.

引用

页码：1024 / 1037

页数：14

共 87 条

[51]

Monti LD, 2005, HERZ, V30, P48, DOI 10.1007/s00059-005-2638-0

[52] Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes [J].

Murthy, Venkatesh L. ;

Naya, Masanao ;

Taqueti, Viviany R. ;

Foster, Courtney R. ;

Gaber, Mariya ;

Hainer, Jon ;

Dorbala, Sharmila ;

Blankstein, Ron ;

Rimoldi, Ornella ;

Camici, Paolo G. ;

Di Carli, Marcelo F. .

CIRCULATION, 2014, 129 (24) :2518-2527

[53] International standardization of diagnostic criteria for microvascular angina [J].

Ong, Peter ;

Camici, Paolo G. ;

Beltrame, John F. ;

Crea, Filippo ;

Shimokawa, Hiroaki ;

Sechtem, Udo ;

Kaski, Juan Carlos ;

Merz, C. Noel Bairey .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 250 :16-20

[54]

Pan CS, 2021, FRONT PHYSIOL, V12

[55]

Pan Jie, 2021, Zhongguo Zhong Yao Za Zhi, V46, P2325, DOI [10.19540/j.cnki.cjcmm.20210322.501, 10.19540/j.cnki.cjcmm.20210322.501]

[56]

Pang Wen-Tai, 2019, Zhongguo Zhong Yao Za Zhi, V44, P2390, DOI 10.19540/j.cnki.cjcmm.20190305.005

[57]

Peng DG, 2011, CHINESE J INTEGRATIV, V9, P746

[58] Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury [J].

Qi, Kang ;

Li, Lujin ;

Li, Xiangdong ;

Zhao, Jinglin ;

Wang, Yang ;

You, Shijie ;

Hu, Fenghuan ;

Zhang, Haitao ;

Cheng, Yutong ;

Kang, Sheng ;

Cui, Hehe ;

Duan, Lian ;

Jin, Chen ;

Zheng, Qingshan ;

Yang, Yuejin .

PLOS ONE, 2015, 10 (03)

[59]

Qin G, 2017, CHINESE J INTEGRATIV, V15, P2807

[60]

Qin H.F., 2017, J MED FORUM, V38, P147

← 1 2 3 4 5 6 7 8 9 →